See up to 3 months of MRUS. The 7-day demo opens the 1M and 3M ranges and puts MRUS on your watchlist.
Start 7-day demoLatest MRUS insider trades
About Merus N.V. (MRUS)
Merus N.V. is an SEC registrant, filing under CIK 0001651311, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
MRUS Form 4 activity by transaction type, last 90 days
No Form 4 activity for MRUS in the last 90 days.
MRUS insider transactions (Form 4)
14522 Form 4 filings on record, the earliest from May 22, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| A/S Genmab | Open-market purchase | Common Shares, nominal value EUR 0.09 per share | 2,978 | $97.00 | $289K | |
| A/S Genmab | Open-market purchase | Common Shares, nominal value EUR 0.09 per share | 1,052,806 | $97.00 | $102.12M | |
| A/S Genmab | Open-market purchase | Common Shares, nominal value EUR 0.09 per share | 75,867,199 | $97.00 | - | |
| A/S Genmab | Open-market purchase | Common Shares, nominal value EUR 0.09 per share | 15,710 | $97.00 | $1.52M | |
| A/S Genmab | Open-market purchase | Common Shares, nominal value EUR 0.09 per share | 561,042 | $97.00 | $54.42M | |
| A/S Genmab | Open-market purchase | Common Shares, nominal value EUR 0.09 per share | 96,082 | $97.00 | $9.32M | |
| A/S Genmab | Open-market purchase | Common Shares, nominal value EUR 0.09 per share | 142,610 | $97.00 | $13.83M | |
| A/S Genmab | Open-market purchase | Common Shares, nominal value EUR 0.09 per share | 212,177 | $97.00 | $20.58M | |
| A/S Genmab | Open-market purchase | Common Shares, nominal value EUR 0.09 per share | 66,264 | $97.00 | $6.43M | |
| A/S Genmab | Open-market purchase | Common Shares, nominal value EUR 0.09 per share | 120,752 | $97.00 | $11.71M | |
| A/S Genmab | Open-market purchase | Common Shares, nominal value EUR 0.09 per share | 150,795 | $97.00 | $14.63M | |
| Gregory D. Perry - Officer | Derivative | Share Option (right to buy) | 100,000 | $0.00 | - | |
| Gregory D. Perry - Officer | Derivative | Share Option (right to buy) | 107,300 | $0.00 | - | |
| Gregory D. Perry - Officer | Derivative | Share Option (right to buy) | 372,924 | $0.00 | - | |
| Gregory D. Perry - Officer | Derivative | Share Option (right to buy) | 14,414 | $0.00 | - | |
| Gregory D. Perry - Officer | Derivative | Share Option (right to buy) | 16,604 | $0.00 | - | |
| Gregory D. Perry - Officer | Derivative | Share Option (right to buy) | 6,120 | $0.00 | - | |
| Gregory D. Perry - Officer | Derivative | Share Option (right to buy) | 8,631 | $0.00 | - | |
| Gregory D. Perry - Officer | Derivative | Share Option (right to buy) | 17,000 | $0.00 | - | |
| Gregory D. Perry - Officer | Derivative | Share Option (right to buy) | 5,650 | $0.00 | - | |
| Gregory D. Perry - Officer | Derivative | Share Option (right to buy) | 4,983 | $0.00 | - | |
| Gregory D. Perry - Officer | Derivative | Share Option (right to buy) | 8,500 | $0.00 | - | |
| Anand Mehra | Derivative | Share Option (right to buy) | 13,193 | $0.00 | - | |
| Anand Mehra | Derivative | Share Option (right to buy) | 8,844 | $0.00 | - | |
| Anand Mehra | Derivative | Share Option (right to buy) | 14,414 | $0.00 | - | |
| Anand Mehra | Derivative | Share Option (right to buy) | 16,604 | $0.00 | - | |
| Anand Mehra | Derivative | Share Option (right to buy) | 6,120 | $0.00 | - | |
| Anand Mehra | Derivative | Share Option (right to buy) | 8,631 | $0.00 | - | |
| Anand Mehra | Derivative | Share Option (right to buy) | 17,000 | $0.00 | - | |
| Anand Mehra | Derivative | Share Option (right to buy) | 5,650 | $0.00 | - | |
| Anand Mehra | Derivative | Share Option (right to buy) | 4,983 | $0.00 | - | |
| Anand Mehra | Derivative | Share Option (right to buy) | 8,500 | $0.00 | - | |
| Len Kanavy | Derivative | Share Option (right to buy) | 13,193 | $0.00 | - | |
| Len Kanavy | Derivative | Share Option (right to buy) | 8,844 | $0.00 | - | |
| Len Kanavy | Derivative | Share Option (right to buy) | 14,414 | $0.00 | - | |
| Len Kanavy | Derivative | Share Option (right to buy) | 16,604 | $0.00 | - | |
| Len Kanavy | Derivative | Share Option (right to buy) | 6,120 | $0.00 | - | |
| Len Kanavy | Derivative | Share Option (right to buy) | 8,631 | $0.00 | - | |
| Len Kanavy | Derivative | Share Option (right to buy) | 14,149 | $0.00 | - | |
| Len Kanavy | Derivative | Share Option (right to buy) | 7,669 | $0.00 | - | |
| Len Kanavy | Derivative | Share Option (right to buy) | 8,500 | $0.00 | - | |
| Jason Haddock | Derivative | Share Option (right to buy) | 13,193 | $0.00 | - | |
| Jason Haddock | Derivative | Share Option (right to buy) | 17,688 | $0.00 | - | |
| Peter B. Silverman - Officer | Derivative | Share Option (right to buy) | 50,000 | $0.00 | - | |
| Peter B. Silverman - Officer | Derivative | Share Option (right to buy) | 125,000 | $0.00 | - | |
| Peter B. Silverman - Officer | Derivative | Share Option (right to buy) | 107,300 | $0.00 | - | |
| Peter B. Silverman - Officer | Derivative | Share Option (right to buy) | 3,900 | $0.00 | - | |
| Peter B. Silverman - Officer | Derivative | Share Option (right to buy) | 12,714 | $0.00 | - | |
| Peter B. Silverman - Officer | Derivative | Share Option (right to buy) | 104,000 | $0.00 | - | |
| Peter B. Silverman - Officer | Derivative | Share Option (right to buy) | 20,000 | $0.00 | - | |
| Peter B. Silverman - Officer | Derivative | Share Option (right to buy) | 83,000 | $0.00 | - | |
| Fabian Zohren - Officer | Derivative | Share Option (right to buy) | 50,000 | $0.00 | - | |
| Fabian Zohren - Officer | Derivative | Share Option (right to buy) | 183,943 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Other | Common Shares | 30,297 | $97.00 footnote F1 | $2.94M | |
| Sven Ante Lundberg - Officer | Other | Common Shares | 16,372 | $97.00 footnote F1 | $1.59M | |
| Sven Ante Lundberg - Officer | Other | Common Shares | 9,191 | $97.00 footnote F1 | $892K | |
| Sven Ante Lundberg - Officer | Other | Common Shares | 9,191 | $97.00 footnote F1 | $892K | |
| Sven Ante Lundberg - Officer | Other | Common Shares | 9,192 | $97.00 footnote F1 | $892K | |
| Sven Ante Lundberg - Officer | Other | Common Shares | 9,192 | $97.00 footnote F1 | $892K | |
| Sven Ante Lundberg - Officer | Derivative | Share Option (right to buy) | 312,620 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Derivative | Share Option (right to buy) | 351,628 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Derivative | Share Option (right to buy) | 300,000 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Derivative | Share Option (right to buy) | 360,000 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Derivative | Share Option (right to buy) | 380,000 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Derivative | Share Option (right to buy) | 295,000 | $0.00 | - | |
| ||||||
| Paolo Pucci | Derivative | Share Option (right to buy) | 13,193 | $0.00 | - | |
| Paolo Pucci | Derivative | Share Option (right to buy) | 8,844 | $0.00 | - | |
| Paolo Pucci | Derivative | Share Option (right to buy) | 14,414 | $0.00 | - | |
| Paolo Pucci | Derivative | Share Option (right to buy) | 16,604 | $0.00 | - | |
| Paolo Pucci | Derivative | Share Option (right to buy) | 6,120 | $0.00 | - | |
| Paolo Pucci | Derivative | Share Option (right to buy) | 17,262 | $0.00 | - | |
| Harry Shuman - Officer | Other | Common Shares | 11,002 | $97.00 footnote F1 | $1.07M | |
| Harry Shuman - Officer | Derivative | Share Option (right to buy) | 7,600 | $0.00 | - | |
| Harry Shuman - Officer | Derivative | Share Option (right to buy) | 16,000 | $0.00 | - | |
| Harry Shuman - Officer | Derivative | Share Option (right to buy) | 4,700 | $0.00 | - | |
| Harry Shuman - Officer | Derivative | Share Option (right to buy) | 12,400 | $0.00 | - | |
| Harry Shuman - Officer | Derivative | Share Option (right to buy) | 5,000 | $0.00 | - | |
| Harry Shuman - Officer | Derivative | Share Option (right to buy) | 14,500 | $0.00 | - | |
| Harry Shuman - Officer | Derivative | Share Option (right to buy) | 23,420 | $0.00 | - | |
| Harry Shuman - Officer | Derivative | Share Option (right to buy) | 700 | $0.00 | - | |
| Harry Shuman - Officer | Derivative | Share Option (right to buy) | 27,550 | $0.00 | - | |
| Harry Shuman - Officer | Derivative | Share Option (right to buy) | 500 | $0.00 | - | |
| ||||||
| Victor Sandor | Derivative | Share Option (right to buy) | 13,193 | $0.00 | - | |
| Victor Sandor | Derivative | Share Option (right to buy) | 8,844 | $0.00 | - | |
| Victor Sandor | Derivative | Share Option (right to buy) | 14,414 | $0.00 | - | |
| Victor Sandor | Derivative | Share Option (right to buy) | 16,604 | $0.00 | - | |
| Victor Sandor | Derivative | Share Option (right to buy) | 6,120 | $0.00 | - | |
| Victor Sandor | Derivative | Share Option (right to buy) | 8,631 | $0.00 | - | |
| Victor Sandor | Derivative | Share Option (right to buy) | 17,000 | $0.00 | - | |
| Mark T. Iwicki | Other | Common Shares | 73,576 | $97.00 footnote F1 | $7.14M | |
| Mark T. Iwicki | Derivative | Share Option (right to buy) | 13,193 | $0.00 | - | |
| Mark T. Iwicki | Derivative | Share Option (right to buy) | 8,844 | $0.00 | - | |
| Mark T. Iwicki | Derivative | Share Option (right to buy) | 14,414 | $0.00 | - | |
| Mark T. Iwicki | Derivative | Share Option (right to buy) | 16,604 | $0.00 | - | |
| Mark T. Iwicki | Derivative | Share Option (right to buy) | 6,120 | $0.00 | - | |
| Mark T. Iwicki | Derivative | Share Option (right to buy) | 8,631 | $0.00 | - | |
| Mark T. Iwicki | Derivative | Share Option (right to buy) | 5,650 | $0.00 | - | |
| Mark T. Iwicki | Derivative | Share Option (right to buy) | 4,983 | $0.00 | - | |
| Mark T. Iwicki | Derivative | Share Option (right to buy) | 8,500 | $0.00 | - | |
| ||||||
| Maxine Gowen | Derivative | Share Option (right to buy) | 13,193 | $0.00 | - | |
| Maxine Gowen | Derivative | Share Option (right to buy) | 8,844 | $0.00 | - | |
| Maxine Gowen | Derivative | Share Option (right to buy) | 14,414 | $0.00 | - | |
| Maxine Gowen | Derivative | Share Option (right to buy) | 16,604 | $0.00 | - | |
| Maxine Gowen | Derivative | Share Option (right to buy) | 12,240 | $0.00 | - | |
| Maxine Gowen | Derivative | Share Option (right to buy) | 7,957 | $0.00 | - | |
| Harry Shuman - Officer | Option exercise | Common Shares | 800 | $18.61 | $15K | |
| Harry Shuman - Officer | Option exercise | Common Shares | 900 | $24.43 | $22K | |
| Harry Shuman - Officer | Open-market sale | Common Shares | 1,700 | $96.10 | $163K | |
| Harry Shuman - Officer | Grant or award | Share Option (right to buy) | 500 | $0.00 | - | |
| Harry Shuman - Officer | Option exercise | Share Option (right to buy) | 800 | $0.00 | - | |
| Harry Shuman - Officer | Option exercise | Share Option (right to buy) | 900 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Gift | Common Shares | 30,297 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Gift | Common Shares | 30,297 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Gift | Common Shares | 14,198 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Gift | Common Shares | 12,215 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Gift | Common Shares | 52,369 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Gift | Common Shares | 22,449 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Gift | Common Shares | 24,229 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Gift | Common Shares | 2,538 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Gift | Common Shares | 2,539 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Gift | Common Shares | 2,539 | $0.00 | - | |
| Sven Ante Lundberg - Officer | Gift | Common Shares | 2,539 | $0.00 | - | |
| Harry Shuman - Officer | Option exercise | Common Shares | 800 | - footnote F1 | - | |
| Harry Shuman - Officer | Option exercise | Common Shares | 1,000 | - footnote F2 | - | |
| Harry Shuman - Officer | Option exercise | Common Shares | 1,800 | - footnote F3 | - | |
| Harry Shuman - Officer | Option exercise | Common Shares | 2,200 | - footnote F4 | - | |
| Harry Shuman - Officer | Option exercise | Common Shares | 1,500 | - footnote F5 | - | |
| Harry Shuman - Officer | Open-market sale | Common Shares | 8,300 | $95.92 | $796K | |
| Harry Shuman - Officer | Option exercise | Common Shares | 1,000 | - footnote F6 | - | |
| Harry Shuman - Officer | Option exercise | Share Option (right to buy) | 800 | $0.00 | - | |
| Harry Shuman - Officer | Option exercise | Share Option (right to buy) | 1,000 | $0.00 | - | |
| Harry Shuman - Officer | Option exercise | Share Option (right to buy) | 1,800 | $0.00 | - | |
| Harry Shuman - Officer | Option exercise | Share Option (right to buy) | 2,200 | $0.00 | - | |
| Harry Shuman - Officer | Option exercise | Share Option (right to buy) | 1,500 | $0.00 | - | |
| Harry Shuman - Officer | Option exercise | Share Option (right to buy) | 1,000 | $0.00 | - | |
| ||||||
| Peter B. Silverman - Officer | Option exercise | Common Shares | 25,000 | $24.43 | $611K | |
| Peter B. Silverman - Officer | Open-market sale | Common Shares | 25,000 | $60.00 | $1.50M | |
| Peter B. Silverman - Officer | Option exercise | Share Option (right to buy) | 25,000 | $0.00 | - | |
| Peter B. Silverman - Officer | Option exercise | Common Shares | 6,695 | $18.61 | $125K | |
| Peter B. Silverman - Officer | Open-market sale | Common Shares | 6,695 | $55.00 | $368K | |
| Peter B. Silverman - Officer | Option exercise | Common Shares | 16,805 | $18.61 | $313K | |
| Peter B. Silverman - Officer | Open-market sale | Common Shares | 16,805 | $55.00 | $924K | |
| Peter B. Silverman - Officer | Option exercise | Share Option (right to buy) | 6,695 | $0.00 | - | |
| Peter B. Silverman - Officer | Option exercise | Share Option (right to buy) | 16,805 | $0.00 | - | |
| Maxine Gowen | Grant or award | Share Option (right to buy) | 13,193 | $0.00 | - | |
MRUS insider trading FAQ
What is the latest insider trade for MRUS?
Merus N.V. (MRUS) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-12-30. The full record for MRUS runs to 22 Form 4 filings, the earliest from 2025-05-22. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MRUS stock?
No insider purchases of MRUS were filed in the last 90 days. 11 purchases are on record for this company.
How many insiders are selling MRUS stock?
No insider sales of MRUS were filed in the last 90 days. 5 sales are on record for this company.
Where can I see MRUS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MRUS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - A/S Genmab view on EDGAR
- - A/S Genmab view on EDGAR
- - A/S Genmab view on EDGAR
- - A/S Genmab view on EDGAR
- - Gregory D. Perry view on EDGAR
- - Anand Mehra view on EDGAR
- - Len Kanavy view on EDGAR
- - Jason Haddock view on EDGAR
- - Peter B. Silverman view on EDGAR
- - Fabian Zohren view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where MRUS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MRUS with a 7-day demo
- MRUS on your watchlist
- Every MRUS Form 4 filing on record
- Up to 3 months of MRUS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
